The approval of chimeric antigen receptor T-cell (CAR-T) therapies for relapsed/refractory multiple myeloma (RRMM) has significantly advanced treatment options.

Read More> https://multiplemyeloma.pocn.com/patient-management/advancements-in-car-t-therapy-for-rrmm-highlight-crucial-role-of-nursing-professionals/